Understanding GM2 in the Japanese Chin: Protecting Our Breed’s Future

As breeders, exhibitors, and owners, we can all agree on a shared goal, protecting the health and future of the Japanese Chin. GM2, also known as Gangliosidosis, is rare but does poses a very real danger to our breed’s well-being. By understanding what this disease is, how it is inherited, and the value of specific genetic testing, we can work together to protect the health of the Japanese Chin while preserving the breed’s genetic diversity.

Imagine a lively Japanese Chin puppy, bright eyes, playful spirit, and all the charm our breed is known for. Now imagine, by just 9 months of age, that same puppy begins to stumble, lose balance, show signs of confusion. Within a short time, seizures, blindness, and weakness develops. Unfortunately, this is reality with GM2 Gangliosidosis, a fatal neurological disease in our breed. With modern genetic testing, GM2 can be completely prevented. Awareness, responsible breeding and open communication, we as a community can ensure that no Japanese Chin ever suffers from this disease again.

Whether you’re a lifelong Chin enthusiast or just beginning your journey with the breed, you might be asking yourself, what is GM2, known as Gangliosidosis? It was Dr. John Cummings and his colleagues that first identified GM2 in the Japanese Chin in 1985, later Dr. Philip Wood showed that it was caused by a deficiency of an enzyme essential for normal brain function. GM2 in the veterinarian community we call a lysosomal storage disease. In simple terms, it’s caused by a genetic mutation that prevents a dog’s body from breaking down certain fatty substances in the brain. These substances build up, then damaging the nervous system. Carriers (dogs with one of the genes) appear perfectly healthy and affected (dogs with two copies of the genes) develop severe symptoms, usually between 6 to 9 months of age. However, once the symptoms begin, the disease progresses quickly, unfortunately, affected dogs rarely live beyond two to three years.

Let’s break down GM2 Gangliosidosis further. Inside every cell of the body is a “recycling center” called the lysosome. Its job is to break down old or worn-out molecules so their building blocks can be reused. In the brain, one of the most important molecules being recycled is called a “ganglioside”. These gangliosides sit in the surface membrane of brain cells and help the cells communicate with each other. That communication is what allows dogs (and people) to move, feel, and think. Normally, when gangliosides wear out, they are sent to the lysosome where special enzymes break them down. But in dogs with GM2 gangliosidosis, one of those enzymes is missing. Without it, the recycling process stalls. Instead of being cleared away, the old gangliosides pile up inside the brain cells. A simple way to picture this is to imagine cooking dinner but never being able to take out the trash. At first, you can still cook, but as the garbage builds up, eventually you can’t get to the stove or the refrigerator. The same thing happens inside the brain cell, the buildup eventually blocks the cell from doing its job, leading to progressive brain disease. (Adapted from the University of Missouri College of Veterinary Medicine)

Why does this matter for our Breed and why is it so important to test? Though GM2 is rare, its impact is devastating, not only for the dogs, but for the families and breeders who love them. Because carriers show no outward signs, it is impossible to know a dog’s status without a DNA test. This makes awareness and testing critical for anyone breeding and owning Japanese Chins. Today, several canine genetic testing companies offer DNA testing for GM2 gangliosidosis in the Japanese Chin. Here are a few laboratories that offer genetic testing and are accepted by the OFA.

• Embark Veterinary: Includes GM2 on its comprehensive DNA testing panel, with results for clear, carrier, or affected status.
• Wisdom Panel – Offers GM2 testing as part of its breed health panel.
• Other Veterinary Diagnostic Labs – Some specialty labs (such as UC Davis, VetGen or Paw Print Genetics) may also include GM2 in their toy breed testing packages.

OFA/CHIC (Orthopedic Foundation for Animals/Canine Health Information Center) OFA accepts GM2 test results as part of its health database and encourages breeders to submit results for public records. This transparency helps protect the breed. Japanese Chin puppies can be tested as early of 4 weeks of age.

OFA does have genetic GM2 available to order and a list of accepted laboratories: https://ofa.org/laboratories/

The OFA’s recommendation is that all breeding dogs be tested prior to being bred, and that results be made available in the public OFA/CHIC database. This allows breeders to make informed pairing decisions while protecting genetic diversity. The Japanese Chin Club of America (JCCA) strongly supports health testing for breeding dogs, including GM2 gangliosidosis. The club encourages members to test, submit results, and share information with other breeders to prevent affected puppies from being born.

It is a shared responsibility. As breeders, exhibitors, and pet owners, we all play a critical role in protecting the health of the Japanese Chin. GM2 gangliosidosis may be rare, but it is a serious threat, and one we have the power to eliminate. Testing, transparency, and responsible breeding choices are our strongest tools. As stewards of this beloved breed, let us use them wisely to preserve the health, spirit, and beauty of the Japanese Chin for generations to come.

References & Resources

University of Missouri, College of Veterinary Medicine. Lysosomal Storage Diseases in Dogs and Cats. https://cvm.missouri.edu

Orthopedic Foundation for Animals (OFA) / Canine Health Information Center (CHIC). Genetic Testing Recommendations and Health Databases. https://ofa.org

Embark Veterinary. GM2 Gangliosidosis Testing Information. https://embarkvet.com

Wisdom Panel. Genetic Health Testing for Dogs. https://www.wisdompanel.com

AKC Canine Health Foundation. Genetics, Research, and Breed Health Initiatives. https://akcchf.org

Scientific References

Cummings, J.F., et al. (1985). GM2 Gangliosidosis in Japanese Chins. Journal of Inherited Metabolic Disease.

Wood, P.A., et al. (1990s). Enzymatic Deficiencies in Canine Lysosomal Storage Diseases.

Freeman, A.C., Platt, S.R., Vandenberg, M., Holmes, S., Kent, M., Rech, R., Howerth, E., Mishra, S., O’Brien, D.P., Wenger, D. (2013). GM2 Gangliosidosis (B variant) in two Japanese Chins: Clinical, Magnetic Resonance Imaging, and Pathological Characteristics. Journal of Veterinary Internal Medicine, 27(4), 771–776. doi:10.1111/jvim.12118.